These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8426361)

  • 1. Highly selective tripeptide thrombin inhibitors.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Gesellchen PD
    J Med Chem; 1993 Feb; 36(3):314-9. PubMed ID: 8426361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
    Shuman RT; Rothenberger RB; Campbell CS; Smith GF; Gifford-Moore DS; Paschal JW; Gesellchen PD
    J Med Chem; 1995 Oct; 38(22):4446-53. PubMed ID: 7473571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A; Ehrhardt C; Metternich R; Tapparelli C
    Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
    Harmat NJ; Di Bugno C; Criscuoli M; Giorgi R; Lippi A; Martinelli A; Monti S; Subissi A
    Bioorg Med Chem Lett; 1998 May; 8(10):1249-54. PubMed ID: 9871744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active site-directed synthetic thrombin inhibitors: synthesis, in vitro and in vivo activity profile of BMY 44621 and analogs. An examination of the role of the amino group in the D-Phe-Pro-Arg-H series.
    Balasubramanian N; St Laurent DR; Federici ME; Meanwell NA; Wright JJ; Schumacher WA; Seiler SM
    J Med Chem; 1993 Jan; 36(2):300-3. PubMed ID: 8423602
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
    Odake S; Kam CM; Powers JC
    J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
    Jetten M; Peters CA; Visser A; Grootenhuis PD; van Nispen JW; Ottenheijm HC
    Bioorg Med Chem; 1995 Aug; 3(8):1099-114. PubMed ID: 7582983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
    Callas D; Bacher P; Iqbal O; Hoppensteadt D; Fareed J
    Thromb Res; 1994 May; 74(3):193-205. PubMed ID: 8042188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of selective thrombin inhibitors based on the (R)-Phe-Pro-Arg sequence.
    Danilewicz JC; Abel SM; Brown AD; Fish PV; Hawkeswood E; Holland SJ; James K; McElroy AB; Overington J; Powling MJ; Rance DJ
    J Med Chem; 2002 Jun; 45(12):2432-53. PubMed ID: 12036353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retro-binding thrombin active site inhibitors: identification of an orally active inhibitor of thrombin catalytic activity.
    Iwanowicz EJ; Kimball SD; Lin J; Lau W; Han WC; Wang TC; Roberts DG; Schumacher WA; Ogletree ML; Seiler SM
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3183-6. PubMed ID: 12372529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hirulog peptides with scissile bond replacements resistant to thrombin cleavage.
    Kline T; Hammond C; Bourdon P; Maraganore JM
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1049-55. PubMed ID: 2059196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A family of arginal thrombin inhibitors related to efegatran.
    Smith GF; Shuman RT; Craft TJ; Gifford DS; Kurz KD; Jones ND; Chirgadze N; Hermann RB; Coffman WJ; Sandusky GE; Roberts E; Jackson CV
    Semin Thromb Hemost; 1996; 22(2):173-83. PubMed ID: 8807715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective inhibition of thrombin by peptides of boroarginine.
    Kettner C; Mersinger L; Knabb R
    J Biol Chem; 1990 Oct; 265(30):18289-97. PubMed ID: 2211702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitors, part 13: Specific, weakly basic thrombin inhibitors incorporating sulfonyl dicyandiamide moieties in their structure.
    Clare BW; Scozzafava A; Supuran CT
    J Enzyme Inhib; 2001 Jan; 16(1):1-13. PubMed ID: 11496831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.